Biovision

Results: 216



#Item
31NMR-BIO Endorsed by: LyonBiopôle Project holder : KERFAH Rime Engineer Institut de Biologie Structurale Organization :

NMR-BIO Endorsed by: LyonBiopôle Project holder : KERFAH Rime Engineer Institut de Biologie Structurale Organization :

Add to Reading List

Source URL: www.biovision.org

Language: English - Date: 2015-03-26 11:01:13
32DIABELOOP One line pitch: Artificial Pancreas service for Diabetes treatment. We will save lives, amputations, ocular and renal complications, and radically improve everyday life for the patients.  Market Analysis:

DIABELOOP One line pitch: Artificial Pancreas service for Diabetes treatment. We will save lives, amputations, ocular and renal complications, and radically improve everyday life for the patients. Market Analysis:

Add to Reading List

Source URL: www.biovision.org

Language: English - Date: 2015-03-26 10:58:53
33I SONIC MEDICAL One line pitch: A quantum leap in glaucoma detection and monitoring, all about vision expectancy. Market Analysis: First addressable market size is worth $150 M with professional tonometers towards

I SONIC MEDICAL One line pitch: A quantum leap in glaucoma detection and monitoring, all about vision expectancy. Market Analysis: First addressable market size is worth $150 M with professional tonometers towards

Add to Reading List

Source URL: www.biovision.org

Language: English - Date: 2015-03-26 11:00:47
34EFFIMUNE One line pitch: THE IMMUNE REGULATION COMPANY Market Analysis: The total market size of immunomodulator drugs was $46.8 billion inThe 3 main markets

EFFIMUNE One line pitch: THE IMMUNE REGULATION COMPANY Market Analysis: The total market size of immunomodulator drugs was $46.8 billion inThe 3 main markets

Add to Reading List

Source URL: www.biovision.org

Language: English - Date: 2015-03-26 10:59:05
35GAMAMABS PHARMA One line pitch: Gamamabs develops innovative antibodies which activate effector cells in oncology. Gamamabs lead antibody is in pre-IMPD stage and targets AMHRII in ovarian cancer  Market Analysis:

GAMAMABS PHARMA One line pitch: Gamamabs develops innovative antibodies which activate effector cells in oncology. Gamamabs lead antibody is in pre-IMPD stage and targets AMHRII in ovarian cancer Market Analysis:

Add to Reading List

Source URL: www.biovision.org

Language: English - Date: 2015-03-26 10:59:50
36OPSONA THERAPEUTICS One line pitch: Dublin based Irish Biotech Company with focus on development of anti-inflammatory therapeutics targeting major disease areas supported by a blue chip investor consortium.  Market Analy

OPSONA THERAPEUTICS One line pitch: Dublin based Irish Biotech Company with focus on development of anti-inflammatory therapeutics targeting major disease areas supported by a blue chip investor consortium. Market Analy

Add to Reading List

Source URL: www.biovision.org

Language: English - Date: 2015-03-26 11:01:38
37NEOLYS DIAGNOSTICS One line pitch: Neolys Diagnostics is a Lyon based service ( MDIVD) company providing a personalised decision tool to radio-oncologists for all cancer patients undergoing radiotherapy.  Market Analysis

NEOLYS DIAGNOSTICS One line pitch: Neolys Diagnostics is a Lyon based service ( MDIVD) company providing a personalised decision tool to radio-oncologists for all cancer patients undergoing radiotherapy. Market Analysis

Add to Reading List

Source URL: www.biovision.org

Language: English - Date: 2015-03-26 11:01:19
38CILOA SAS One line pitch: An exosome-based breakthrough technology to develop a new generation of safe, affordable and efficient vaccines responding to any future pandemic virus threats.  Market Analysis:

CILOA SAS One line pitch: An exosome-based breakthrough technology to develop a new generation of safe, affordable and efficient vaccines responding to any future pandemic virus threats. Market Analysis:

Add to Reading List

Source URL: www.biovision.org

Language: English - Date: 2015-03-26 10:58:32
39extranet.insight-outsidecatalyzer1426586080

extranet.insight-outsidecatalyzer1426586080

Add to Reading List

Source URL: www.biovision.org

- Date: 2015-03-26 11:01:58
    40AXILUM ROBOTICS One line pitch: Axilum Robotics has developed and commercializes robotized solution to improve Transcranial Magnetic Stimulation in depression, pain and stroke rehabilitation  COMPANY PROFILE

    AXILUM ROBOTICS One line pitch: Axilum Robotics has developed and commercializes robotized solution to improve Transcranial Magnetic Stimulation in depression, pain and stroke rehabilitation COMPANY PROFILE

    Add to Reading List

    Source URL: www.biovision.org

    Language: English - Date: 2015-03-26 10:58:23